Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Eva Koriťáková, RNDr., PhD, Michael Doubek, MD PhD, Edgar Faber, MD PhD, Daniela Žáčková, MD PhD, Jan M. Horáček, MD PhD, Petra Bělohlávková, MD PhD, Eduard Cmunt, MD PhD, František Folber, MD PhD, Pavel Jindra, MD PhD, Hana Klamová, MD PhD, Zdeněk Kořístek, MD PhD, Lukáš Stejskal, MD, Tomáš Szotkowski, MD PhD, Cyril Šálek, MD PhD, Renata Kellnerová, MD PhD, Marika Chrápavá, Mgr.

Blood (2019) 134 (Supplement_1): 5905.

https://doi.org/10.1182/blood-2019-126395

Published: 2019

Journal Articles

Characterization of Pathogenic Variants Associated with Hereditary Thrombocytopenias in Families from the Czech Republic

Zuzana Vrzalova, PhD, Katerina Stano Kozubik, PhD, Lenka Radova, PhD, Jakub Trizuljak, MD, Sarka Pospisilova, Prof PhD, Michael Doubek, MD PhD

Blood (2019) 134 (Supplement_1): 2343.

https://doi.org/10.1182/blood-2019-122696

Published: 2019

Journal Articles

Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg

Yair Herishanu, MD, Adir Shaulov, MD, Riva Fineman, MD, Sandra Bašić-Kinda, MD, Ariel Aviv, MD, Ewa Wasik-Szczepanek, MD PhD, Ozren Jaksic, MD PhD, Mihnea Zdrenghea, MD, Uri Greenbaum, MD, Inga Mandac, MD, Martin Simkovic, MD PhD, Marta Morawska, MD, Ohad Benjamini, MD, Martin Spacek, MD, Anatoly Nemets, MD, Osnat Bairey, MD PhD, Andrea Visentin, MD, Rosa Ruchlemer, MD, Luca Laurenti, MD, Oana Stanca Ciocan, MD, Michael Doubek, MD PhD, Lev Shvidel, MD, Nagib Deli, MD, Fatima Miras Calvo, MD, Anne De Meûter, Maria Dimou, MD PhD, Francesca Romana Mauro, MD, Marta Coscia, MD PhD, Horia Bumbea, MD PhD, Szász Róbert, Tamar Tadmor, MD, Odit Gutwein, Massimo Gentile, Lydia Scarfo, MD, Alessandra Tedeschi, MD, Paolo Sportoletti, Eva Gimeno Vázquez, Juan Marquet Palomanes, MD, Sarit Assouline, MD, Maria Papaioannou, Andrei Breaster, MD, Luciano Levato, MD, Michael Gregor, MD, Gian Matteo Rigolin, MD, Javier Loscertales, MD, Angeles Medina Perez, MD, Marten R. Nijziel, MD PhD, Viola Maria Popov, MDPhDMSc, Rosa Collado, MD, Irma Slavutsky, Shai Levi, MSc, Aaron Polliack, MD, Paolo Ghia, MD PhD

Blood (2019) 134 (Supplement_1): 1766.

https://doi.org/10.1182/blood-2019-122309

Published: 2019

Journal Articles

Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 TM and RESONATE TM with RW Databases

Gilles Andre Salles, MD, Evelyne Callet-Bauchu, Hervé Besson, Margaret Doyle, Jamie Garside, Martin Spacek, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4427.

https://doi.org/10.1182/blood-2018-99-112172

Published: 2018

Journal Articles

Epigenetic Drug Screen on Resistant CLL Cells Reveals Aurora Kinase Inhibitors As Enhancers of CD20 Expression and Sensitizers to Treatment with CD20 Monoclonal Antibodies

Veronika Kozlova, Aneta Ledererova, Michael Doubek, MD PhD, Jiri Mayer, MD, Sarka Pospisilova, Michal Smida, PhD MSc

Blood (2018) 132 (Supplement 1): 4407.

https://doi.org/10.1182/blood-2018-99-118669

Published: 2018

Journal Articles

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression

Blood (2018) 132 (Supplement 1): 1834.

https://doi.org/10.1182/blood-2018-99-116325

Published: 2018

Journal Articles

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Galina Salogub, MD PhD, Jiri Mayer, MD, Frantisek Folber, MD PhD, Sebastian Grosicki, MD PhD, Aleksander B Skotnicki, MD PhD, Anna Prochwicz, MD, Alexander Myasnikov, MD, Alexander Gural, MD, Oliver Schoenborn-Kellenberger, MSc, Charlie Brindley, PhD, Stefan Knackmuss, PhD, Sylvia Schwarz, PhD, Sandra Schmich, Cassandra Choe-Juliak, MD MS, Andras Strassz, MD, Leila Alland, MD, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 3969.

https://doi.org/10.1182/blood-2018-99-118136

Published: 2018

Journal Articles

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Zuzana Vrzalova, PhD, Hana Jelinkova, Stepan Hrabovsky, Frantisek Folber, MD PhD, Cyril Salek, Jan Horacek, Marketa Zaliova, Jiri Stika, Martina Slavikova, Sarka Pospisilova, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4090.

https://doi.org/10.1182/blood-2018-99-118308

Published: 2018

Journal Articles

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Gilles Salles, MD PhD, Lukas Smolej, MD PhD, Emmanuel Bachy, Lucile Baseggio, MD, Hervé Besson, Ruben Hermans, Nollaig Healy, Jamie Garside, Wafae Iraqi, Joris Diels, Finlay MacDougall, Corinna Pick-Lauer, Martin Spacek, Renata Urbanova, Daniel Lysak, Evelyne Callet-Bauchu, Michael Doubek, MD PhD

Blood (2017) 130 (Supplement 1): 5342.

https://doi.org/10.1182/blood.V130.Suppl_1.5342.5342

Published: 2017

Journal Articles

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Blood (2017) 130 (Supplement 1): 3273.

https://doi.org/10.1182/blood.V130.Suppl_1.3273.3273

Published: 2017

Journal Articles

Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)

Massimiliano Bonifacio, MD, Patrizia Bonadonna, MD, Hanneke Oude Elberink, MD, Björn van Anrooij, MD, Aleksandra Górska, MD, Magdalena Lange, MD, Emir Hadzijusufovic, DVM, Luigi Scaffidi, Ilaria Tanasi, MD, Cecelia Perkins, Virginia Valeria Ferretti, Anja Illerhaus, PhD, Thilo Jakob, MD, Roberta Parente, MD, Mohamad Jawhar, MD, Francesca Caroppo, MD, Alexander Zink, MD, Alex Kilbertus, MD, Akif Selim Yavuz, MD, Michael Doubek, MD PhD, Hans Hagglund, MD PhD, Jens P. Panse, MD, Vito Sabato, MD PhD, Elisabeth Aberer, MD, Nadja Jaekel, MD, Peter Vandenberghe, MD PhD, David Fuchs, MD, Knut Brockow, MD, Anna Belloni Fortina, MD, Andreas Reiter, MD, Massimo Triggiani, MD, Khalid Shoumariyeh, MD, Karin Hartmann, MD, Chiara Elena, Olivier Hermine, MD PhD, Jason Gotlib, MD, Marek Niedoszytko, MD, Hanneke Kluin-Nelemans, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Roberta Zanotti, MD

Blood (2017) 130 (Supplement 1): 4200.

https://doi.org/10.1182/blood.V130.Suppl_1.4200.4200

Published: 2017

Journal Articles

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Blood (2017) 130 (Supplement 1): 1650.

https://doi.org/10.1182/blood.V130.Suppl_1.1650.1650

Published: 2017

Journal Articles

Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry

Kamila Brazdilova, MSc., Karla Plevova, PhD, Hana Skuhrova Francova, MSc, Helena Kockova, MSc, Magdalena Chmelikova, MSc, Marek Borsky, MSc., Katerina Burckova, MSc, Barbara Kantorova, MSc, Boris Tichy, PhD, Hana Skabrahova, Yvona Brychtova, PhD, MD, Jiri Mayer, Prof, MD PhD, Michael Doubek, MD PhD, Sarka Pospisilova, Prof.

Blood (2015) 126 (23): 4139.

https://doi.org/10.1182/blood.V126.23.4139.4139

Published: 2015

Journal Articles

The Regulation, Targets and Clinical Relevance of Microrna Mir-650 in Chronic Lymphocytic Leukemia (CLL),

Marek Mraz, MD, Karla Plevova, Dasa Dolezalova, Katerina Stano-Kozubik, Veronika Mayerova, Katerina Cerna, Katerina Musilova, Sarka Pavlova, Dr., Boris Tichy, Dr., Jana Lochmanova, Michael Doubek, MD, PhD, Yvona Brychtova, MD, Martin Trbusek, PhD, Ales Hampl, Jiri Mayer, Sarka Pospisilova, Dr, PhD

Blood (2011) 118 (21): 3874.

https://doi.org/10.1182/blood.V118.21.3874.3874

Published: 2011

Journal Articles

Mutational Analysis of Mir-29 Family Members in Chronic Lymphocytic Leukemia

Jana Lochmanova, PharmD, Marek Mraz, MD, Veronika Navrkalova, Barbora Dvorakova, Boris Tichy, Dr, Karla Plevova, Ludmila Sebejova, Dr, Jitka Malcikova, Dr, Sarka Pavlova, PhD, Vladimir Benes, Tobias Rausch, Dr, Yvona Brychtova, MD, Michael Doubek, MD, PhD, Martin Trbusek, PhD, Jiri Mayer, Sarka Pospisilova, Dr

Blood (2011) 118 (21): 1770.

https://doi.org/10.1182/blood.V118.21.1770.1770

Published: 2011

Journal Articles

Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Michael Doubek, MD, PhD, Martin Simkovic, MD, Anna Panovska, MD, Monika Hrudkova, MD, David Belada, MD, PhD, Yvona Brychtova, MD, Jiri Mayer, MD, PhD, Lukas Smolej, M.D., Ph.D.

Blood (2010) 116 (21): 4629.

https://doi.org/10.1182/blood.V116.21.4629.4629

Published: 2010

Journal Articles

Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group

Lukas Smolej, M.D., Ph.D., Martin Spacek, M.D., Yvona Brychtova, MD, David Belada, M.D., Ph.D., Jiri Schwarz, M.D., Ph.D., Michael Doubek, MD, PhD, Monika Motyckova, M.D., Eduard Cmunt, M.D., Ph.D., Peter Rohon, MD, Katerina Klaskova, M.S., Tomas Kozak, M.D., Ph.D.

Blood (2010) 116 (21): 2466.

https://doi.org/10.1182/blood.V116.21.2466.2466

Published: 2010

Journal Articles

Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients

Karla Plevova, Hana Skuhrova Francova, Boris Tichy, Dr, Jitka Malcikova, Dr., Sarka Pavlova, Dr., Ondrej Horky, Olga Stehlikova, Michael Doubek, MD, PhD, Yvona Brychtova, MD, Jiri Mayer, MD, PhD, Sarka Pospisilova, Dr, PhD

Blood (2010) 116 (21): 2412.

https://doi.org/10.1182/blood.V116.21.2412.2412

Published: 2010

Journal Articles

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Jiri Mayer, MD, Jan Kamelander, MD, Zdenek Pospisil, MSc, Michael Doubek, MD, PhD, Marta Krejci, MD, PhD

Blood (2008) 112 (11): 4359.

https://doi.org/10.1182/blood.V112.11.4359.4359

Published: 2008

Journal Articles

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Miroslav Penka, Jiri Schwarz, Michael Doubek, MD, PhD, Petr Dulicek, Karel Indrak, Yvona Brychtova, MD, Antonin Hlusí, Jarmila Kissova, Jiri Mayer, MD, Tomas Pavlik

Blood (2008) 112 (11): 5257.

https://doi.org/10.1182/blood.V112.11.5257.5257

Published: 2008

NARROW

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Characterization of Pathogenic Variants Associated with Hereditary Thrombocytopenias in Families from the Czech Republic

Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg

Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 TM and RESONATE TM with RW Databases

Epigenetic Drug Screen on Resistant CLL Cells Reveals Aurora Kinase Inhibitors As Enhancers of CD20 Expression and Sensitizers to Treatment with CD20 Monoclonal Antibodies

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry

The Regulation, Targets and Clinical Relevance of Microrna Mir-650 in Chronic Lymphocytic Leukemia (CLL),

Mutational Analysis of Mir-29 Family Members in Chronic Lymphocytic Leukemia

Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group

Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only